Швеция - шведски - Läkemedelsverket (Medical Products Agency)

ceva santé animale - actinobacillus pleuropneumoniae, apxi-toxoid; actinobacillus pleuropneumoniae, apxii-toxoid; actinobacillus pleuropneumoniae, apxiii-toxoid - injektionsvätska, suspension - tiomersal hjälpämne; aluminiumoxid, hydratiserad adjuvans; actinobacillus pleuropneumoniae, apxi-toxoid 28,9 elisa e aktiv substans; actinobacillus pleuropneumoniae, apxii-toxoid 16,7 elisa e aktiv substans; actinobacillus pleuropneumoniae, apxiii-toxoid 6,8 elisa e aktiv substans - svin

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

ceva santé animale - dinoprosttrometamol - injektionsvätska, lösning - 5 mg/ml - dinoprosttrometamol 6,7 mg aktiv substans; bensylalkohol hjälpämne - nöt, svin

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

ceva santé animale - dinoprosttrometamol - injektionsvätska, lösning - 12,5 mg/ml - dinoprosttrometamol 16,8 mg aktiv substans; bensylalkohol hjälpämne - nöt

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

ceva santé animale - gonadorelindiacetattetrahydrat - injektionsvätska, lösning - 50 mikrogram/ml - bensylalkohol hjälpämne; gonadorelindiacetattetrahydrat 58 mikrog aktiv substans - nöt

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

orifarm ab - erysipelothrix rhusiopathiae, serotyp 2, inaktiverad; svinparvovirus, inaktiverat - injektionsvätska, suspension - aluminiumoxid, hydratiserad 4,2 mg adjuvans; erysipelothrix rhusiopathiae, serotyp 2, inaktiverad 1 elisa e aktiv substans; svinparvovirus, inaktiverat 100 hie aktiv substans; tiomersal hjälpämne - svin

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

orifarm ab - erysipelothrix rhusiopathiae, serotyp 2, inaktiverad; svinparvovirus, inaktiverat - injektionsvätska, suspension - erysipelothrix rhusiopathiae, serotyp 2, inaktiverad 1 elisa e aktiv substans; svinparvovirus, inaktiverat 100 hie aktiv substans; aluminiumoxid, hydratiserad 4,2 mg adjuvans; tiomersal hjälpämne - svin

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

ceva santé animale - firocoxib - tuggtablett - 250 mg - firocoxib 250 mg aktiv substans; laktosmonohydrat hjälpämne - hund

Швеция - шведски - Läkemedelsverket (Medical Products Agency)

ceva santé animale - firocoxib - tuggtablett - 62,5 mg - firocoxib 62,5 mg aktiv substans; laktosmonohydrat hjälpämne - hund

Европейски съюз - шведски - EMA (European Medicines Agency)

ceva santé animale - inactivated fimbrial adhesins of escherichia coli f4ab, inactivated fimbrial adhesins of escherichia coli f4ac, inactivated fimbrial adhesins of escherichia coli f5, inactivated fimbrial adhesins of escherichia coli f6 - immunologiska medel för suidae - grisar - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6.

Европейски съюз - шведски - EMA (European Medicines Agency)

ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - grisar - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:-           clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6-           clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins-           clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.